Suanfarma Italia
Italy
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (5)
○ MHRA GMP
✓ HC GMP (3)
Quick Facts: Suanfarma Italia
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Italy
- Website
- https://www.suanfarma.com/
- Modalities
- Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Suanfarma Italia
Suanfarma Italia makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 2 manufacturing sites registered with the U.S. FDA and Health Canada: Rovereto, Italy and its sister Suanfarma site CIPAN in Castanheira do Ribatejo, Portugal. Website: https://www.suanfarma.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Suanfarma Italia FDA Inspection History
2023-03
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2023-03-03 |
Suanfarma Italia S.p.A.
Rovereto
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Suanfarma Italia EMA GMP Compliance 5 certificates
2024-12
2023-03
2021-03
2019-05
2019-05
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| NBF/8/2025/V | Suanfarma Italia S.p.A. | Italy | 2024-12-18 | COMPLIANT |
| IT-API/247/H/2023 | Suanfarma Italia S.p.A. | Italy | 2023-03-03 | COMPLIANT |
| IT-API/75/H/2021 | SUANFARMA ITALIA S.P.A. | Italy | 2021-03-03 | COMPLIANT |
| IT-API/17/H/2020 | SUANFARMA ITALIA S.P.A. | Italy | 2019-05-09 | COMPLIANT |
| IT-API/8/H/2020 | SUANFARMA ITALIA S.P.A. | Italy | 2019-05-09 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Suanfarma Italia
How many FDA inspections does Suanfarma Italia have on record?
CDMO Signal tracks 1 FDA inspection for Suanfarma Italia, sourced from the FDA inspection database. See the full inspection history above.
Has Suanfarma Italia received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Suanfarma Italia.
Does Suanfarma Italia hold EMA or MHRA GMP certificates?
CDMO Signal tracks 5 EMA GMP certificates for Suanfarma Italia.
Does Suanfarma Italia have a CDMO Signal Score?
Not yet. Suanfarma Italia is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Suanfarma Italia for a manufacturing program?
Use the free AI matchmaker to compare Suanfarma Italia against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Olon
Rodano (Milano), Italy
Small Molecule API, Biologics, ADC / Bioconjugation
ICROM
Concorezzo (MB), Italy
Small Molecule API, Intermediates, Custom Synthesis
ACS Dobfar
Italy
Small Molecule API, Sterile Fill-Finish
Dipharma Francis
Italy
Small Molecule API
F.I.S. Fabbrica Italiana Sintetici
Italy
Small Molecule API
Compare Suanfarma Italia with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.